Company / Operating Income per Share
Phio Pharmaceuticals Corp. Operating Income per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$13.42
FY2020
5-year range
-$21.50 / -$1.57
FY2016-FY2020
Trend
+37.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 7 years, ranging from $-21.50 in FY2019 to $-0.13 in FY2012.
Based on SEC 10-K filings.
-13.42 in FY2020.
Declined from $-5.79 to $-13.42 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating income per share increased 37.5% year-over-year.
- Peak operating income per share was recorded in FY2012.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$13.42 | +37.5% |
| FY2019 | -$21.50 | -271.5% |
| FY2018 | -$5.79 | +16.5% |
| FY2017 | -$6.93 | -342.6% |
| FY2016 | -$1.57 | +36.1% |
| FY2013 | -$2.45 | -1829.5% |
| FY2012 | -$0.13 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026